Asthma attacks are the primary driver of adverse outcomes and costs. For payors, this burden is $82B in the US annually. For patients, attacks lead to airway remodeling, permanent loss of lung function, and life-altering side effects from frequent systemic steroid use. Our solution combines a patented Dx and digital solution to identify risk of attack up to 20 days before symptoms to enable simple and proactive interventions to prevent attacks.